RedHill Biopharma Ltd. (RDHL)
0.4232
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.4213
0.00 (0.00%)
After-Hours: 20:00
RedHill Biopharma Price to Book Value : 0.0192 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.0192 |
| October 22, 2026 | 0.0192 |
| October 21, 2026 | 0.0207 |
| October 20, 2026 | 0.023 |
| October 19, 2026 | 0.0228 |
| October 16, 2026 | 0.0218 |
| October 15, 2026 | 0.0227 |
| October 14, 2026 | 0.0221 |
| October 13, 2026 | 0.0234 |
| October 12, 2026 | 0.0242 |
| October 09, 2026 | 0.0245 |
| October 08, 2026 | 0.0263 |
| October 07, 2026 | 0.0215 |
| October 06, 2026 | 0.022 |
| October 05, 2026 | 0.0224 |
| October 02, 2026 | 0.0227 |
| October 01, 2026 | 0.0218 |
| September 30, 2026 | 0.0218 |
| September 29, 2026 | 0.0219 |
| September 28, 2026 | 0.023 |
| September 25, 2026 | 0.0227 |
| September 24, 2026 | 0.0236 |
| September 23, 2026 | 0.0247 |
| September 22, 2026 | 0.0246 |
| September 21, 2026 | 0.025 |
| Date | Value |
|---|---|
| September 18, 2026 | 0.0258 |
| September 17, 2026 | 0.0269 |
| September 16, 2026 | 0.025 |
| September 15, 2026 | 0.0261 |
| September 14, 2026 | 0.0279 |
| September 11, 2026 | 0.0293 |
| September 10, 2026 | 0.0297 |
| September 09, 2026 | 0.0316 |
| September 08, 2026 | 0.0295 |
| September 04, 2026 | 0.0329 |
| September 03, 2026 | 0.0324 |
| September 02, 2026 | 0.0337 |
| September 01, 2026 | 0.0395 |
| August 31, 2026 | 0.0409 |
| August 28, 2026 | 0.03 |
| August 27, 2026 | 0.0286 |
| August 26, 2026 | 0.028 |
| August 25, 2026 | 0.0275 |
| August 24, 2026 | 0.0275 |
| August 21, 2026 | 0.0286 |
| August 20, 2026 | 0.0284 |
| August 19, 2026 | 0.0285 |
| August 18, 2026 | 0.0269 |
| August 17, 2026 | 0.0266 |
| August 14, 2026 | 0.0273 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 5.922 |
| MediWound Ltd. | 4.346 |
| Purple Biotech Ltd. | 0.1424 |
| Sol-Gel Technologies Ltd. | 4.728 |
| PolyPid Ltd. | 19.79 |
Price to Book Value Related Metrics
| PS Ratio | 6.145 |
| Price | 0.4232 |
| Earnings Yield | -666.6% |
| Market Cap | 2.573M |